Evidence map

TrialDiabetes care2021

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11).

Juan P Frias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

96 papers cite itlatest 60 shown

2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33397768